THW, C., L, A., C, B., E, D., J, E., T, E., . . . B, K. (2024). Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: Protocol for a randomized, waitlist-controlled trial with blinded ratings. Frontiers in psychiatry, 14, 1278823. https://doi.org/10.3389/fpsyt.2023.1278823
Chicago Style (17th ed.) CitationTHW, Ching, et al. "Safety, Feasibility, Tolerability, and Clinical Effects of Repeated Psilocybin Dosing Combined with Non-directive Support in the Treatment of Obsessive-compulsive Disorder: Protocol for a Randomized, Waitlist-controlled Trial with Blinded Ratings." Frontiers in Psychiatry 14 (2024): 1278823. https://doi.org/10.3389/fpsyt.2023.1278823.
MLA (9th ed.) CitationTHW, Ching, et al. "Safety, Feasibility, Tolerability, and Clinical Effects of Repeated Psilocybin Dosing Combined with Non-directive Support in the Treatment of Obsessive-compulsive Disorder: Protocol for a Randomized, Waitlist-controlled Trial with Blinded Ratings." Frontiers in Psychiatry, vol. 14, 2024, p. 1278823, https://doi.org/10.3389/fpsyt.2023.1278823.
